Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107899611A enables visible light asymmetric hydroxylation using molecular oxygen. Delivers cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN107899611A introduces a visible light organocatalyst for asymmetric hydroxylation, offering cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Novel patent CN105175250B offers safer ciprofibrate synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates globally.
Novel photocatalytic route for phosphazene compounds using iron. Mild conditions, high yield, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN102311352B details a safe, cost-effective 3-step synthesis from m-cresol, offering significant supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN104910034A details a novel ruthenium-catalyzed synthesis for high-purity alpha-beta-diamino acid derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105688983A reveals novel eight-membered ring catalysts enabling high ee values. Enhances supply chain reliability and reduces manufacturing complexity for chiral intermediates.
Patent CN116284019B reveals green one-step synthesis. High purity, reusable catalyst, cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101023092A discloses stable chiral ligands enabling efficient asymmetric hydrogenation. Enhances supply chain reliability and reduces manufacturing costs for global buyers.
Patent CN112209965A details a high-yield rhodium-catalyzed asymmetric hydrogenation route for chiral beta-aminophosphine precursors, offering significant supply chain and cost advantages.
Patent CN110105293B details a visible-light driven method for synthesizing C-3 difluoromethyl quinoxalinones, offering a greener, safer route for pharmaceutical intermediate manufacturing.
Patent CN103183612A reveals a homogeneous alkylation method for dipropylmalonic acid diester, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN113117753B introduces a hydrophobic catalyst for high-yield beta-ionone production, eliminating sulfuric acid waste and enabling mild reaction conditions.
Patent CN118373733A reveals a novel visible-light organophosphine catalyzed route for high-purity difluorostyrene derivatives, offering significant supply chain and cost advantages.
Novel Pd-Cu catalytic synthesis ensures high yield and purity for pharmaceutical intermediates. Reduces costs and enhances supply chain reliability for global buyers.
Patent CN105712889B reveals a cost-effective route for Ticagrelor intermediates. Discover kinetic resolution benefits and supply chain advantages for pharmaceutical manufacturing.
Patent CN116854624A reveals safer continuous synthesis for pyrrolidine intermediates. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN104693092A reveals a one-step synthesis for PTP1B inhibitors. Discover cost reduction and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN117362252B details a bio-based furan route to FDCM. Offers safer Claisen reaction and scalable polymer intermediate production for global supply chains.
Patent CN105779555B details a one-step microbial conversion for prednisolone intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.